technetium Tc 99m epratuzumab

{
  "id": "MLC-T-ONC-017015",
  "term": "technetium Tc 99m epratuzumab",
  "field": "Oncology and biomedicine",
  "definition": "A radioimmunoconjugate of the humanized IgG1 monoclonal antibody (MoAb) LL2 labeled with Technetium 99m (Tc-99m). Epratuzumab (MoAb LL2) recognizes CD22, a B-lymphocyte-restricted antigen expressed as a cytoplasmic protein in progenitor B cells, and as a cell surface protein in mature B cells. Tc-99m epratuzumab delivers gamma emission Tc-99m directly to B-lymphocyte lineage cells, thereby the agent may be used for diagnostic or treatment purposes.",
  "abbreviation": "Tc 99m LL2",
  "synonyms": [
    "Tc 99m monoclonal antibody LL2",
    "technetium Tc 99m LL2 monoclonal antibody",
    "technetium Tc 99m monoclonal antibody LL2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/technetium-tc-99m-epratuzumab/"
}